AQR Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

AQR Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,084	Closed	-$691K	–	2475
2023 Q3	$691K	Sell	4,084 -1,169	-22%	-$220K	﹤0.01%	1739
2023 Q2	$1.14M	Sell	5,253 -595	-10%	-$127K	﹤0.01%	1499
2023 Q1	$1.06M	Sell	5,848 -7,118	-55%	-$1.36M	﹤0.01%	1520
2022 Q4	$2.55M	Buy	12,966 +1,308	+11%	+$280K	0.01%	1159
2022 Q3	$2.62M	Buy	11,658 +9,145	+364%	+$1.85M	0.01%	1093
2022 Q2	$318K	Buy	+2,513	New	+$289K	﹤0.01%	1846
2021 Q1	–	Sell	-2,857	Closed	-$290K	–	2286
2020 Q4	$290K	Buy	+2,857	New	+$265K	﹤0.01%	1984

Other funds holding KRTX

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

AQR Capital Management's KRTX Position: Q4 2023 in Review

AQR Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 4,084 shares — an estimated $691K sold.

AQR Capital Management first reported a position in KRTX in Q4 2020 and held it in 7 quarters. The position peaked at $2.62M in Q3 2022. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

AQR Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
AQR Capital Management sold 4,084 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $691K.
AQR Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
AQR Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $2.62M in Q3 2022.
328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.